Author:
Weiss Thomas,Griesshaber Joachim,Rogatti Waltraud,Wilhelm Claudia,Diehm Curt,Kübler Wolfgang
Subject
Cardiology and Cardiovascular Medicine
Reference18 articles.
1. Balzer K, Rogatti W, Rüttgerodt K (1989) Efficacy and tolerability of intraarterial and intravenous prostaglandin E1 infusions in occlusive arterial disease stage III/IV. VASA 28(Suppl):31–38.
2. Braun M, Ney P, Szymansky Ch, et al. (1991) 13,14-dihydro-PGE1 a potent inhibitor of human platelet and neutrophil activation. Br J Pharmacol 102:90.
3. Carlson LA, Eriksson F (1973) Femoral-artery infusion of prostaglandin E1 in severe peripheral vascular disease. Lancet I:155–156.
4. Carlson LA, Olsson AG (1976) Intravenous prostaglandin E1 in severe peripheral vascular disease. Lancet II:810.
5. Creutzig A, Caspary L, Alexander K (1986) Skin surface oxygen pressure fields during administration of prostaglandin E1 in patients with arterial occlusive disease. Klin Wochenschr 68:207–212.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献